PHCCC

PHCCC is a research drug which acts as a glutamate receptor ligand, particularly being a positive allosteric modulator at the mGluR4 subtype, as well as an agonist at mGluR6. It has anxiolytic effects in animal studies. PHCCC and similar drugs have been suggested as novel treatments for Parkinson's disease.


PHCCC is a research drug which acts as a glutamate receptor ligand, particularly being a positive allosteric modulator at the mGluR4 subtype, as well as an agonist at mGluR6. It has anxiolytic effects in animal studies. PHCCC and similar drugs have been suggested as novel treatments for Parkinson's disease.
Read article on Wikipedia

PHCCC

 je istraživački lek koji deluje kao ligand glutamatnog receptora. On je pozitivni alosterni modulator 4 podtipa, kao i agonist 6. On ispoljava anksiolitičko dejstvo u životinjskim studijama. i slični lekovi su potencijalne nove terapije za Parkinsonovu bolest.


je istraživački lek koji deluje kao ligand glutamatnog receptora. On je pozitivni alosterni modulator 4 podtipa, kao i agonist 6. On ispoljava anksiolitičko dejstvo u životinjskim studijama. i slični lekovi su potencijalne nove terapije za Parkinsonovu bolest.
Read article on Wikipedia